Monitoring treatment response in breast cancer is of great importance and FDG PET has demonstrated its utility in this indication. FDG PET must be performed in patients with advanced disease treated ...
Reston, Va.—Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission ...
Characterization of TP53 mutations in actionable driver-negative non-small cell lung cancer (NSCLC). This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not ...
Expert Rev Anticancer Ther. 2009;9(1):75-96. Based on the available data, FDG-PET alone appears to be of limited use in differentiating tumors of low malignant potential from benign tumors and ovarian ...
Reston, VA… FDG PET detected recurrent cancer 50% more often than did conventional imaging in persons suffering from thyroid cancer who had indications that their ...
Management of testicular neoplasms in France and compliance with national guidelines. Background: The use of FDG-PET for the evaluation of postchemotherapy seminoma residuals has been recommended by ...
Staging locally advanced breast cancer patients with 18 F-labeled fluorodeoxyglucose (FDG) PET-CT detected more distant metastases -- and thus reduced the number of patients who received combined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results